Latanoprost Ratiopharm

Latanoprost, the active ingredient in Latanoprost Ratiopharm, is a prostaglandin analog presented as eye drops for ocular use. It is employed to lower intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension, helping to preserve visual function.

GNH USA supplies Latanoprost Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established quality‑assurance processes and regulatory compliance across EU and global markets. The company provides reliable logistics, documentation support, and post‑supply technical assistance to ensure uninterrupted patient care.

Latanoprost is a prostaglandin analog used to manage ocular pressure in glaucoma and related conditions. - Open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. - Ocular hypertension: lowers eye pressure to prevent development of glaucoma. - Secondary open‑angle glaucoma (e.g., pseudoexfoliative): helps control pressure in secondary forms of the disease.

Latanoprost may cause ocular and systemic reactions.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris darkening: gradual pigmentation change. - Eye irritation: transient burning or stinging sensation.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Uveitis or iritis: inflammation of the uveal tract. - Macular edema: fluid accumulation affecting central vision.

Before using Latanoprost, consider the following precautions. - Monitor intra‑ocular pressure: schedule regular measurements after initiation. - Assess for ocular infections: avoid use if active infection is present. - Avoid contact lenses: discontinue lens wear during treatment. - Caution in patients with history of uveitis: monitor closely for inflammation. - Pregnancy and lactation: use only if potential benefit justifies the potential risk. - Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost may interact with other ocular medications.

Major Interactions (Avoid): - Concomitant prostaglandin analog eye drops: increased risk of ocular side effects. - Use with preservative‑containing anesthetic drops: may enhance irritation. - Systemic carbonic anhydrase inhibitors: additive intra‑ocular pressure reduction, requiring monitoring.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: possible reduction in Latanoprost efficacy. - Beta‑blocker eye drops: additive pressure‑lowering effect, monitor IOP. - Topical corticosteroids: may counteract pressure‑lowering action of Latanoprost.